Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas.
In the present paper we review the results of our study on the use of monoclonal antibodies Y13,259 to the ras p21 and MYC1 9E10 to the c-myc p62 oncoprotein products in human tumors and tumorlike conditions of the colorectum. A total of 78 tissue sections were analyzed immunohistochemically and revealed the following: 42 adenocarcinomas with 8 normal mucosae adjacent to the tumor, 25 adenomas (with or without dysplasia and with in situ carcinoma) and 3 hyperplastic polyps. Parallel tissue sections were used in order to compare ras and c-myc oncoproteins. Reviewing our results we made the following remarks: 1. All adenocarcinomas but one were expressed with both oncoproteins, most of them being strongly positive. 2. All adenomas were positive for ras p21, and all but two were also positive for c-myc p62. An interesting point is that the degree of staining intensity increased in accordance with the degree of dysplasia and/or in situ carcinoma association. 3. The hyperplastic polyps, as well as all normal mucosae were negative.
Dept. of Pathology, Hellenic Anticancer Institute Saint Savvas Hospital, Athens, Greece.
N J
NJ
Agnantis
N
N
Apostolikas
C
C
Sficas
V
V
Zolota
D A
DA
Spandidos
D000236:Adenoma / Q000737:chemistry / Q000378:metabolism*; D002277:Carcinoma / Q000737:chemistry / Q000378:metabolism*; D003110:Colonic Neoplasms / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D015689:Oncogene Protein p21(ras) / Q000032:analysis / Q000096:biosynthesis*; D016271:Proto-Oncogene Proteins c-myc / Q000032:analysis / Q000096:biosynthesis*
D016271:Proto-Oncogene Proteins c-myc; D015689:Oncogene Protein p21(ras)